Announcement on behalf of OBIGEN of resolution to lift the non-competition restrictions for directors
2025.May.20
Announcement on behalf of OBIGEN of important resolutions of 2025 Annual Shareholders’ meeting and accumulated losses amounting to 50% of paid-in capital
2025.May.12
The Board of Directors resolved to issue new common shares by private placement
2025.May.12
The Company's Board of Directors resolved to convene the 2025 Annual General Shareholders' Meeting (Additional matters)
2025.May.12
The BOD resolved to rename the Audit Committee to the Audit and Risk Management Committee
2025.May.12
The BOD resolved to rename the Remuneration Committee to the Remuneration and Nomination Committee
2025.May.12
Announcement of the Consolidated Financial Statements for the first quarter of 2025 were approved by the Board of Directors
2025.May.12
Announcement on behalf of Amaran that its institutional director changes its representative
2025.May.12
Announcement on behalf of Amaran of the resignation of its representative of institutional director
2025.May.12
Announcement of change of Chief Scientific Officer